Authors:
MORSDORF S
JUNG F
SEYFERT UT
MROWIETZ C
PINDUR G
WENZEL E
Citation: S. Morsdorf et al., HEMOSTATIC AND RHEOLOGICAL ASPECTS OF DYSFIBRINOGENEMIA, Clinical hemorheology and microcirculation, 17(1), 1997, pp. 13-19
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., A MORE DIFFERENTIATED CLASSIFICATION OF HYDROXYETHYL STARCHES IS NECESSARY, Intensive care medicine, 23(6), 1997, pp. 709-710
Authors:
GROSS J
PINDUR G
MORSDORF S
WAGNER B
SEYFERT UT
WENZEL E
Citation: J. Gross et al., FAMILIARY PROTEIN-Z DEFICIENCY - CLINICAL AND LABORATORY STUDIES IN 2FAMILIES, Thrombosis and haemostasis, 1997, pp. 2610-2610
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
JUNG F
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., INCREASED HEMORRHAGIC RISK AFTER REPEATED INFUSION OF HIGHLY SUBSTITUTED MEDIUM MOLECULAR-WEIGHT HYDROXYETHYL STARCH, Arzneimittel-Forschung, 47(1), 1997, pp. 18-22
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., AVOIDING AN IMPAIRMENT OF FACTOR VIII-C BY USING HYDROXYETHYL STARCH WITH A LOW IN-VIVO MOLECULAR-WEIGHT, Anesthesia and analgesia, 84(6), 1997, pp. 1391-1391
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., DECREASE OF FIBRONECTIN FOLLOWING REPEATED INFUSION OF HIGHLY SUBSTITUTED HYDROXYETHYL STARCH, Infusionstherapie und Transfusionsmedizin, 23(2), 1996, pp. 71-75
Authors:
TREIB J
HAASS A
PINDUR G
TREIB W
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., INFLUENCE OF INTRAVASCULAR MOLECULAR-WEIGHT OF HYDROXYETHYL STARCH ONPLATELETS, European journal of haematology, 56(3), 1996, pp. 168-172
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
SEYFERT UT
TREIB W
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., INFLUENCE OF LOW-MOLECULAR-WEIGHT HYDROXYETHYL STARCH (HES 40 0.5-0.55) ON HEMOSTASIS AND HEMORHEOLOGY/, Haemostasis, 26(5), 1996, pp. 258-265
Authors:
TREIB J
HAASS A
PINDUR G
MIYACHITA C
GRAUER MT
JUNG F
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., HIGHLY SUBSTITUTED HYDROXYETHYL STARCH (HES-200 0.62) LEADS TO TYPE-IVON-WILLEBRAND SYNDROME AFTER REPEATED ADMINISTRATION/, Haemostasis, 26(4), 1996, pp. 210-213
Authors:
JUNG F
MEIER C
KOSCIELNY J
PINDUR G
MOLL A
SCHIMETTA W
KIESEWETTER H
Citation: F. Jung et al., EFFECTS OF A HYPERVOLEMIC HEMODILUTION WITH HES-100 0.5 10-PERCENT INPATIENTS WITH PAOD STAGE-II - ELIMINATION KINETICS AND BLOOD FLUIDITY/, Clinical hemorheology, 16(5), 1996, pp. 631-643
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., DECREASE IN PLATELET VOLUME AFTER INFUSIO N OF HIGHLY SUBSTITUTED MEDIUM MOLECULAR-WEIGHT HYDROXYETHYL STARCH (HES-200 0.62) FOR SEVERAL DAYS/, Wiener Klinische Wochenschrift, 108(1), 1996, pp. 20-23
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., ALL MEDIUM STARCHES ARE NOT THE SAME - INFLUENCE OF THE DEGREE OF HYDROXYETHYL SUBSTITUTION OF HYDROXYETHYL STARCH ON PLASMA-VOLUME, HEMORRHEOLOGIC CONDITIONS, AND COAGULATION, Transfusion, 36(5), 1996, pp. 450-455
Authors:
TREIB J
HAASS A
PINDUR G
GRAUER MT
TREIB W
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., INFLUENCE OF LOW AND MEDIUM MOLECULAR-WEIGHT HYDROXYETHYL STARCH ON PLATELETS DURING A LONG-TERM HEMODILUTION IN PATIENTS WITH CEREBROVASCULAR DISEASES, Arzneimittel-Forschung, 46(11), 1996, pp. 1064-1066
Authors:
JUNG F
BLASI U
RADTKE H
MROWIETZ C
PINDUR G
KIESEWETTER H
WENZEL E
Citation: F. Jung et al., PLATELETPHERESIS-INDUCED INCREASE IN PLATELET REACTIVITY USING DIFFERENT CELL SEPARATORS, Infusionstherapie und Transfusionsmedizin, 22(4), 1995, pp. 237-243
Authors:
RADTKE H
BACHMANN K
PINDUR G
KOSCIELNY J
WENZEL E
KIESEWETTER H
Citation: H. Radtke et al., GUIDELINES REQUIRED BY LAW FOR THE MANAGE MENT OF COMPLAINTS OF SIDE-EFFECTS OF BLOOD COMPONENTS, Infusionstherapie und Transfusionsmedizin, 22(3), 1995, pp. 186-195
Authors:
KOSCIELNY J
JUNG F
MROWIETZ C
KIESEWETTER H
PINDUR G
WENZEL E
Citation: J. Koscielny et al., RHEOLOGICAL AND CAPILLARY-MICROSCOPIC PAR AMETERS FOR DIAGNOSIS OF VON WILLEBRAND-JURGENS SYNDROME, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 45-47
Authors:
TREIB J
HAASS A
PINDUR G
SEYFERT UT
TREIB W
GRAUER MT
JUNG F
WENZEL E
SCHIMRIGK K
Citation: J. Treib et al., HES-200 0.5 IS NOT HES-200/0.5 - INFLUENCE OF THE C2/C6 HYDROXYETHYLATION RATIO OF HYDROXYETHYL STARCH (HES) ON HEMORHEOLOGY, COAGULATION AND ELIMINATION KINETICS/, Thrombosis and haemostasis, 74(6), 1995, pp. 1452-1456
Authors:
KIESEWETTER H
ERDLENBRUCH K
KOSCIELNY J
JUNG F
PINDUR G
WENZEL E
Citation: H. Kiesewetter et al., EFFICACY OF HYPERVOLUMETRIC HEMODILUTION WITH HES-200 0.5 6-PERCENT VERSUS RINGER LACTATE IN PATIENTS WITH ASYSTEMIC VERTIGO/, Clinical hemorheology, 15(4), 1995, pp. 601-611